Dr. Charlene Liu, Founder of RiskWise Solution, Delivered Keynote at 2Firsts Compliance Symposium

Jan.16.2025
Dr. Charlene Liu, Founder of RiskWise Solution, Delivered Keynote at 2Firsts Compliance Symposium
The 2025 Global NGP Compliance Development Symposium successfully concludes in Shenzhen, focusing on promoting global compliance in the industry.

On January 9, 2025, the 2025 Global NGP Compliance Development Symposium, organized by 2Firsts, concluded successfully in Shenzhen. The symposium aimed to promote global compliance development and encourage companies to actively embrace the new era of compliance. Over 10 renowned compliance experts and industry representatives from China and around the world delivered keynote speeches through a combination of online and offline formats, attracting nearly 200 participants from various sectors, including international tobacco companies, leading e-cigarette companies in China, top supply chain companies, and researchers. The conference was organized by the world's leading NGP industry media and consultancy - 2Firsts.

 

Dr. Charlene Liu, Founder of RiskWise Solution, Delivered Keynote at 2Firsts Compliance Symposium
Dr. Charlene Liu's speech scene | Image source: 2Firsts

 

Dr. Charlene Liu, founder of RiskWise Solution, participated in the symposium and delivered an online presentation titled "The Impact of FDA's 2024 APPH Science Policy Memorandum on Compliance Development in the E-cigarette Industry."

 

Dr. Charlene Liu, Founder of RiskWise Solution, Delivered Keynote at 2Firsts Compliance Symposium
Dr. Charlene Liu's speech | Image source: 2Firsts

 

Dr. Charlene Liu thoroughly explained the FDA's regulatory requirements for e-cigarette products, the pathway for tobacco products to be marketed in the United States, and the scientific research framework for new tobacco products. She also provided detailed guidance on how companies can ensure their products meet the standards for protecting public health through quantitative risk assessment.

 

Dr. Charlene Liu, Founder of RiskWise Solution, Delivered Keynote at 2Firsts Compliance Symposium
Dr. Charlene Liu interacts with the live audience through a video connection | Image source: 2Firsts

 

Dr. Charlene Liu also provided key measures for Chinese e-cigarette companies to create high-quality, safe, and compliant e-cigarette products, offering clear guidance for companies looking to enter the American market.

 

In addition, Dr. Charlene Liu also interacted live with the audience in the United States. The interactive session on this topic was hosted by Dr. Xinan Liu, a researcher at the Brain Institute of the Shenzhen Advanced Institute of the Chinese Academy of Sciences. With guidance from the two scientists, the audience engaged in an in-depth discussion.

 

Dr. Charlene Liu's professional speech received high recognition and enthusiastic feedback from attendees. After the symposium, attendees provided positive feedback, stating that the information provided valuable guidance for them as they expand into the American market. Attendees also expressed sincere gratitude to the organizers, believing that the event created a high-quality compliance communication platform that greatly facilitated communication and interaction among industry stakeholders, effectively promoting the industry's steady development on the compliance path.

 

As a leading media and think tank in the field of New Generation Products (NGP) globally, 2Firsts actively maintains close contact with various testing and regulatory agencies, building a solid bridge for industry resource sharing and information exchange. In the future, 2Firsts will continue to integrate resources, gather wisdom, and work with industry partners to jointly promote the high-quality development of the global NGP industry, contributing lasting strength to the industry's innovation breakthroughs and compliance.

 


Regarding RiskWise Solution

 

RiskWise Solution is a leading tobacco product toxicology and health risk assessment company based in the United States, specializing in providing comprehensive services for regulatory applications for new tobacco products. We are committed to helping new tobacco products successfully enter the international markets in Europe and America, and have achieved outstanding results in product authorization and applications in the United States.

 

RiskWise focuses on research related to modules 3 and 4 of the PMTA, covering key services including product design and production compliance, product chemical characteristics and long-term stability research, in vivo and in vitro toxicology testing protocols, and assessment of health and safety risks of novel tobacco products.

 

RiskWise offers clients a one-stop consulting service for new tobacco products, from concept to market, including e-liquid ingredient analysis, smoking material evaluation, research and development strategy formulation, and regulatory submission. RiskWise prides itself on collaborations with top experts and former FDA CTP officials, who can be involved in specific projects and provide long-term strategic support.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Swedish nicotine pouch brand Kelly White is building its strategy around adult female consumers. Founder and CEO Sophia Wilsby told 2Firsts that women accounted for around 70% of the brand’s repeat customers on HAYPP in Sweden in 2025. The interview explores female consumer segmentation, product and design differentiation, gender stereotypes, packaging regulation, and how independent brands can compete with global players such as ZYN and VELO while considering funding, partnerships and future ownership options.
Business
Sep.24
Global Nicotine-Pouch E-Commerce Group Haypp Shuts Sweden’s Snusnetto Over Age Verification as Identity Checks Become Industry Infrastructure for New Nicotine Products
Global Nicotine-Pouch E-Commerce Group Haypp Shuts Sweden’s Snusnetto Over Age Verification as Identity Checks Become Industry Infrastructure for New Nicotine Products
Sweden's Supreme Administrative Court has declined to hear an appeal over age verification for tobacco and nicotine products collected from parcel lockers, leaving in place a lower-court ruling that geo-located BankID verification is insufficient to securely verify the actual recipient. Haypp Group has stopped tobacco and nicotine sales through Snusnetto and is deploying a new system across its other Swedish e-commerce sites to verify the age of the person who actually opens the locker and receives the shipment. The change comes as age verification across next-generation nicotine products expands from purchase checks into retail, delivery and, for some e-cigarettes, device access itself.
Regulations
Oct.20
Product | OXVA Introduces XLIM PRO 4 With Liquid-Level Anti-Burn Technology and Dedicated Pods
Product | OXVA Introduces XLIM PRO 4 With Liquid-Level Anti-Burn Technology and Dedicated Pods
Vaping brand OXVA introduced the XLIM PRO 4 refillable pod system in October 2026, featuring Anti-Burn Tech (ABT) based on smart e-liquid-level detection. The system can issue refill alerts and stop power output when e-liquid levels become too low. ABT requires the XLIM PRO 4 device and a dedicated XLIM ABT cartridge. Standard XLIM pods remain compatible but do not support ABT protection. OXVA previously introduced temperature-based anti-burn technology in the XLIM Pro 2 DNA, developed with Evolv. The new device features a 1,800mAh battery, 5–30W output and a 0.98-inch HD color screen. OXVA's official store lists the device at $37.90 and dedicated ABT replacement cartridges at $12.99. Independent testing confirmed the low-liquid protection response but recorded varying cartridge lifespans.
product
Oct.30
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Pennsylvania began enforcing its electronic nicotine delivery system directory restrictions on October 19, 2026. Among 163 product listings recorded before enforcement, four CrossBar 20K disposables stood out with 13mL capacity, advertised puff counts of up to 20,000 and a flattened design distinct from conventional pod systems and compact disposables. Historical records identify earlier 1.3mL CrossBar products associated with Romo LLC, while newer 13mL products appeared in several state directories beginning in 2025 under entities including Blue Nine LLC. PMTA compliance expert Mr. K identified amendments and application ownership transfers as possible regulatory mechanisms, although neither has been confirmed in this case. Separately, Reynolds' $7.5 million acquisition of 16 PACHA products and related assets illustrates the commercial value of products linked to historic PMTA submissions.
Special Report
Oct.22
Juul Displays FDA-Authorized JUUL2, Highlights Age Verification at NACS Show 2026
Juul Displays FDA-Authorized JUUL2, Highlights Age Verification at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Juul Labs displayed its JUUL2 e-cigarette system alongside existing products, age-verification messaging and mobile coupons, 2Firsts observed. The JUUL2 device and Virginia Tobacco and Polar Menthol pods received FDA marketing authorization in August 2026. Booth materials highlighted longer battery life, greater e-liquid capacity and connected-device features. A TruAge sign and a mobile coupon presentation also featured at the booth, with weekly offers available to age-verified adult nicotine consumers at participating retailers.
EXPO
Oct.09
FDA Authorizes 24 VELO Nicotine Pouches, Increasing U.S. Authorized Total by 56%
FDA Authorizes 24 VELO Nicotine Pouches, Increasing U.S. Authorized Total by 56%
The U.S. FDA authorized 24 VELO nicotine pouch products from a British American Tobacco subsidiary, raising the total number of authorized products from 43 to 67, a 55.8% increase. The newly authorized 4 mg products include lime and passion fruit flavors and feature certified child-resistant packaging. VELO's first FDA marketing authorization adds BAT to a list previously limited to PMI and Altria products, while bringing the agency's nicotine pouch review pilot total to 47 authorized products.
Oct.30